Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Manufacturing
CDMO Avid to go private in $1.1B deal
CDMO Avid has agreed to be acquired by funds managed by Ampersand and GHO Capital Partners in an all-cash deal worth $1.1 billion.
Fraiser Kansteiner
Nov 7, 2024 2:50pm
Pharmacosmos scoops up G1 Therapeutics in $405M deal
Aug 7, 2024 11:28am
FTC seeks more data from Pfizer, Seagen on their $43B merger
Jul 17, 2023 10:35am
SEC charges former Alexion VP Joseph Dupont with insider trading
Jun 30, 2023 8:40am
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo
May 10, 2023 11:25am
Assertio picks up Spectrum and approved drug in $248M-plus deal
Apr 25, 2023 1:49pm
